<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03380338</url>
  </required_header>
  <id_info>
    <org_study_id>Bootcamp2</org_study_id>
    <nct_id>NCT03380338</nct_id>
  </id_info>
  <brief_title>The Effect of Exercise on Gut Microbiota in Type 2 Diabetic Patients</brief_title>
  <official_title>Lifestyle Intervention in Patients With Diabetes Type 2 and the Association With the Gut Microbiota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether targeted lifestyle intervention (exercise), induces a change in
      intestinal fecal microbiota related to improved glycemic control and systemic inflammation in
      patients with DM type 2.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diet and exercise are the most beneficial lifestyle interventions in patients with diabetes
      mellitus (DM) type 2, causing an increase in glucose tolerance.

      One of the mechanisms through which these treatment modalities work might be explained
      through changes in the gut microbiota. Recent studies show that the chronic inflammatory
      status causing insulin resistance in DM type 2, is triggered by an increase in circulating
      bacterial lipopolysaccharide (LPS). Strict lifestyle intervention, such as exercise, so
      called Diabetes Bootcamp (DB), may manipulate the gut microbiota, reducing circulating LPS,
      causing an improvement of the insulin-mediated
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 11, 2016</start_date>
  <completion_date type="Actual">June 29, 2017</completion_date>
  <primary_completion_date type="Actual">June 29, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in gut microbiota composition upon exercise</measure>
    <time_frame>At baseline, after 7 weeks, after 13 weeks</time_frame>
    <description>alfa-diversity, beta-diversity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in insulin senistivity</measure>
    <time_frame>Before and after exercise</time_frame>
    <description>Rate of disappearance measured by the hyperinsulinemic-euglycemic clamp with stable glucose isotopes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in resting energy expenditure</measure>
    <time_frame>Before and after exercise</time_frame>
    <description>Indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in continous cardiovascular monitoring</measure>
    <time_frame>Before and after exercise</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Insulin Sensitivity/Resistance</condition>
  <arm_group>
    <arm_group_label>Exercise program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twice weekly exercise program, combined aerobic and strenght training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Combined aerobic and strength exercise</intervention_name>
    <arm_group_label>Exercise program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must meet the criteria for diabetes type 2 (a random blood sugar of &gt; 11.1
             mmol/L and/or a fasting blood sugar lever of &gt;7.0 mmol/L and/or a blood sugar of &gt;11.1
             mmol/L two hours after an oral glucose tolerance test and/or an HbA1c level of &gt;47
             mmol/mol).

          -  Male or female (post-menopausal)

          -  Age above 45 years and below 70 years

          -  BMI &gt;30 kg/m2

          -  HbA1c &lt; 80 mmol/mol or &lt; 8,6% Subjects must use metformin

          -  Stable medication use

          -  Stable tension regulation (with or without medication)

          -  Subjects should be able to give informed consent

        Exclusion Criteria:

          -  A history of cardiovascular event (Cerebrovascular event, myocardial infarction or
             pacemaker implantation)

          -  Severe-very severe lung emphysema (GOLD stage III-IV)

          -  Use of any antibiotics or proton pump inhibitor (PPI) in the past three months

          -  Use of any other antidiabetic medication besides metformin (e.g. SU-derivates,
             insulin)

          -  Use of a platelet inhibitor or cumarin derivate during

          -  Subjects participated in a lifestyle programme in the past 6 months (diet or exercise)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2017</study_first_submitted>
  <study_first_submitted_qc>December 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2017</study_first_posted>
  <last_update_submitted>December 15, 2017</last_update_submitted>
  <last_update_submitted_qc>December 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>Erik Serne</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Gut microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

